AI medical imaging software for lung diseases applies machine learning, computer vision, and clinical decision-support techniques to modalities such as chest radiography, computed tomography, and magnetic resonance imaging. Its principal uses include detection support, image triage, quantification of disease patterns, workflow prioritization, and longitudinal monitoring. Adoption is shaped by clinical validation, interoperability, regulatory clearance, cybersecurity, reimbursement, and the ability to integrate safely into radiology and pulmonary-care pathways.

Clinical Workflows Are Shifting from Detection to Integrated Decision Support

The landscape is moving beyond isolated image classification toward tools that support the full diagnostic workflow, including protocol optimization, automated measurements, structured reporting, urgent-case prioritization, and comparison with prior examinations. This shift increases the importance of explainability, calibration across scanners and populations, and human oversight. Effective deployment depends on embedding software into existing picture archiving and communication systems, electronic health records, and multidisciplinary care processes rather than adding another disconnected interface.

Artificial Intelligence Is Increasing Throughput While Raising Governance Requirements

Artificial intelligence can help clinicians manage high imaging volumes, identify subtle findings, reduce repetitive measurement work, and standardize interpretation support. Its cumulative effect is strongest where data are well curated and workflows are clearly defined. At the same time, performance can vary with population characteristics, acquisition protocols, image quality, and disease prevalence. Leaders therefore need continuous monitoring for drift, transparent documentation of intended use, bias assessment, privacy safeguards, and clear rules assigning responsibility for final clinical decisions.

Regional Conditions Determine the Pace and Form of Adoption

North America benefits from mature digital infrastructure, active clinical validation, and established regulatory pathways, while Latin America is influenced by uneven access to imaging capacity, connectivity, and specialist expertise. Europe emphasizes privacy, conformity assessment, interoperability, and health-system evidence across diverse national settings. The Middle East is investing in advanced healthcare infrastructure and centralized services, whereas Africa faces significant differences in equipment availability, connectivity, workforce capacity, and data representativeness. Asia-Pacific combines advanced innovation ecosystems with substantial variation in healthcare access, regulatory maturity, and urban-rural service distribution.

Economic and Security Alliances Shape Procurement and Interoperability Priorities

ASEAN markets commonly prioritize scalable deployment across diverse health systems and cross-border interoperability. BRICS members reflect varied public-sector capacity, domestic technology priorities, and regulatory approaches. The European Union places strong emphasis on privacy, safety, conformity, and interoperable data environments. G7 systems generally have extensive clinical infrastructure but face evidence, workforce, and integration requirements. GCC countries often support centralized digital-health programs and specialist-care expansion. NATO members also give heightened attention to cyber resilience, continuity of operations, secure infrastructure, and supply-chain risk.

Country Contexts Create Distinct Deployment Opportunities and Constraints

Australia and Canada must address dispersed populations and equitable access across large territories. Brazil, Mexico, India, and South Africa face substantial variation in infrastructure, specialist availability, and public-private delivery models. China, Japan, and South Korea combine advanced technical capabilities with distinctive regulatory, procurement, and data-governance environments. France, Germany, Italy, Spain, and the United Kingdom operate within mature healthcare systems where clinical evidence, workflow integration, privacy, and reimbursement are central adoption considerations. Russia's deployment environment is shaped by domestic infrastructure, regulatory conditions, and access to specialized technology. Across the United States, scale of care delivery, regulatory compliance, interoperability, and liability management remain major implementation considerations.

Prioritize Validated Use Cases, Interoperability, and Continuous Clinical Oversight

Industry leaders should begin with clearly defined clinical problems, such as urgent-case triage or reproducible lesion quantification, and evaluate outcomes against clinically meaningful measures rather than technical accuracy alone. They should require representative local validation, subgroup testing, prospective workflow assessment, and transparent documentation of limitations. Procurement should include interoperability standards, cybersecurity controls, auditability, data-retention rules, model-update governance, and service-level expectations. Successful programs also invest in clinician training, escalation procedures, post-deployment monitoring, and structured feedback loops linking radiologists, pulmonologists, technologists, information-technology teams, and patients.

Methodology: Evidence-Based Assessment of Clinical, Technical, and System Factors

This executive summary uses a structured qualitative assessment of the AI medical imaging software landscape for lung diseases. The assessment considers peer-reviewed clinical evidence, regulatory and safety principles, healthcare digitization conditions, imaging workflow requirements, interoperability practices, privacy and cybersecurity expectations, and country- and region-level health-system characteristics. Findings are synthesized thematically across applications, adoption barriers, implementation requirements, and governance considerations. No market estimates, market shares, forecasts, or company-specific claims are used.

Responsible Integration Will Define Long-Term Value

AI medical imaging software can strengthen lung-disease pathways when it is clinically validated, locally appropriate, interoperable, and governed as a continuously monitored medical technology. The strongest results will come from implementations that augment-not replace-professional judgment and that connect technical performance with measurable improvements in timeliness, consistency, access, and patient safety. Regional and country differences make adaptable deployment models essential, while robust evidence and transparent accountability remain the foundation for sustainable use.

Product Code: MRR-3D150775E415

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. AI Medical Imaging Software for Lung Diseases Market, by Component

7.1. Introduction
7.2. Services
- 7.2.1. Managed Services
- 7.2.2. Professional Services
7.3. Software
- 7.3.1. Integrated Platform
- 7.3.2. Standalone Software

8. AI Medical Imaging Software for Lung Diseases Market, by Modality

8.1. Introduction
8.2. Computed Tomography
8.3. Magnetic Resonance Imaging
8.4. Positron Emission Tomography
8.5. X Ray

9. AI Medical Imaging Software for Lung Diseases Market, by Disease Type

9.1. Introduction
9.2. Chronic Obstructive Pulmonary Disease
9.3. Lung Cancer
9.4. Pneumonia
9.5. Tuberculosis

10. AI Medical Imaging Software for Lung Diseases Market, by Application

10.1. Introduction
10.2. Diagnostics
10.3. Monitoring
10.4. Screening
10.5. Surgical Assistance

11. AI Medical Imaging Software for Lung Diseases Market, by End User

11.1. Introduction
11.2. Ambulatory Care
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Research Institutes

12. AI Medical Imaging Software for Lung Diseases Market, by Deployment

12.1. Introduction
12.2. Cloud Based
- 12.2.1. Hybrid Cloud
- 12.2.2. Private Cloud
- 12.2.3. Public Cloud
12.3. On Premise
- 12.3.1. Edge Server
- 12.3.2. Private Data Center

13. AI Medical Imaging Software for Lung Diseases Market, by Region

13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa

14. AI Medical Imaging Software for Lung Diseases Market, by Group

14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO

15. AI Medical Imaging Software for Lung Diseases Market, by Country

15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
- 16.2.1. Concentration Ratio (CR)
- 16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Aidoc Ltd.
17.2. Annalise.ai Pty Ltd
17.3. Arterys, Inc.
17.4. GE HealthCare Inc.
17.5. Infervision Technology Co., Ltd.
17.6. Koninklijke Philips N.V.
17.7. Lunit Inc.
17.8. Optellum Ltd.
17.9. Oxipit Labs UAB
17.10. Qure.ai Technologies Pvt. Ltd.
17.11. Riverain Technologies, LLC
17.12. Siemens Healthineers AG
17.13. Thirona NV
17.14. VIDA Diagnostics, Inc.
17.15. Zebra Medical Vision Ltd.

18. Key Experts

Product Code: MRR-3D150775E415

LIST OF FIGURES

FIGURE 1. Global AI Medical Imaging Software for Lung Diseases Market, Years Considered for the Study
FIGURE 2. Global AI Medical Imaging Software for Lung Diseases Market, Research Design
FIGURE 3. Global AI Medical Imaging Software for Lung Diseases Market, Research Framework
FIGURE 4. Global AI Medical Imaging Software for Lung Diseases Market, Data Triangulation
FIGURE 5. Global AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
FIGURE 6. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 9. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 11. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2025 vs 2032 (%)
FIGURE 17. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global AI Medical Imaging Software for Lung Diseases Market Share, by Key Player, 2025

LIST OF TABLES

TABLE 1. Global AI Medical Imaging Software for Lung Diseases Market Segmentation & Coverage
TABLE 2. Global AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 3. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Managed Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Managed Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Managed Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Professional Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Professional Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Professional Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Integrated Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Integrated Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Integrated Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Standalone Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Standalone Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Standalone Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 23. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Positron Emission Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Positron Emission Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Positron Emission Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 36. Global Chronic Obstructive Pulmonary Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Chronic Obstructive Pulmonary Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Chronic Obstructive Pulmonary Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Tuberculosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Tuberculosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Tuberculosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 49. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Surgical Assistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Surgical Assistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Surgical Assistance Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 75. Global Cloud Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Cloud Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Cloud Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Edge Server Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Edge Server Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Edge Server Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Private Data Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Private Data Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Private Data Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 108. North America AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 110. North America AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 111. North America AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 112. North America AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 113. North America AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 114. North America AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. North America AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. North America AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 117. North America AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 118. North America AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 119. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 121. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 122. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 123. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 124. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 125. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 128. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 129. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 130. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 132. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 133. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 134. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 135. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 136. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Europe AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 139. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 140. Europe AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 141. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 143. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 144. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 145. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 146. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 147. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 150. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 151. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 152. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 154. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 155. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 156. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 157. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 158. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Africa AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 161. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 162. Africa AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 163. Global AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 166. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 167. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 168. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 169. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 170. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 173. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 174. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 175. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 177. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 178. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 179. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 180. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 181. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. GCC AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 184. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 185. GCC AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 186. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 188. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 189. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 190. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 191. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 192. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. European Union AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 195. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 196. European Union AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 197. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 199. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 200. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 201. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 202. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 203. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 206. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 207. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 208. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 210. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 211. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 212. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 213. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 214. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. G7 AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 217. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 218. G7 AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 219. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 221. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 222. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 223. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 224. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 225. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. NATO AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 228. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 229. NATO AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 230. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 231. United States AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 232. United States AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 233. United States AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 234. United States AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 235. United States AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 236. United States AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 237. United States AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. United States AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. United States AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 240. United States AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 241. United States AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 242. Canada AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 243. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 244. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 245. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 246. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 247. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 248. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Canada AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 251. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 252. Canada AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 253. Mexico AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 254. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 255. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 256. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 257. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 258. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 259. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 262. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 263. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 264. Brazil AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 265. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 266. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 267. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 268. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 269. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 270. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 273. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 274. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 275. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 276. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 277. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 278. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 279. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 280. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 281. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 284. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 285. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 286. Germany AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 287. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 288. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 289. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 290. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 291. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 292. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Germany AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 295. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 296. Germany AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 297. France AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
TABLE 298. France AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
TABLE 299. France AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
TABLE 300. France AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
TABLE 301. France AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
TABLE 302. France AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 303. France AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. France AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. France AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 306. France AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
TABLE 307. France AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 308. Russia AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)

T

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION